During the past decade, Unfallkrankenhaus Berlin Neurologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Unfallkrankenhaus Berlin Neurologie" #1 collaborator was "NeuroCure Clinical Research Center, Charite, Berlin" with 2 trials as a collaborator, "Brahms AG" with 1 trials as a collaborator and "Siemens Health Care" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Unfallkrankenhaus Berlin Neurologie" are "Ischemic Stroke" (2 trials). Many other conditions were trialed in "Unfallkrankenhaus Berlin Neurologie" in a lesser frequency.

Most popular intervention types in "Unfallkrankenhaus Berlin Neurologie" are "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Procalcitonin assay - B.R.A.H.M.S PCT ultrasensitive Kryptor" (1 trials). Other intervention names were less common.

The vast majority of trials in "Unfallkrankenhaus Berlin Neurologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Unfallkrankenhaus Berlin Neurologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Unfallkrankenhaus Berlin Neurologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Unfallkrankenhaus Berlin Neurologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".